Jazz Pharmaceuticals plc Quarterly Income Tax Expense (Benefit) in USD from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Jazz Pharmaceuticals plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2011 to Q2 2024.
  • Jazz Pharmaceuticals plc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$30.7M, a 26% decline year-over-year.
  • Jazz Pharmaceuticals plc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$99.2M, a 45.7% increase year-over-year.
  • Jazz Pharmaceuticals plc annual Income Tax Expense (Benefit) for 2023 was -$120M, a 24.4% increase from 2022.
  • Jazz Pharmaceuticals plc annual Income Tax Expense (Benefit) for 2022 was -$159M, a 173% decline from 2021.
  • Jazz Pharmaceuticals plc annual Income Tax Expense (Benefit) for 2021 was $216M, a 545% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$99.2M -$30.7M -$6.33M -26% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 -$92.9M $11.7M +$27M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$120M -$33.1M +$67M +66.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$187M -$47.2M -$4.15M -9.64% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$183M -$24.3M -$8.21M -51% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$175M -$15.3M -$15.9M -2959% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$159M -$100M -$87.6M -702% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$71.1M -$43M -$25M -138% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$46.1M -$16.1M -$245M -107% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $199M $536K -$17.5M -97% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $216M -$12.5M -$23.2M -216% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $239M -$18.1M -$37.3M -194% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $277M $229M +$174M +318% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $103M $18M +$69.3M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $33.5M $10.8M +$45.3M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$11.8M $19.3M +$8.38M +76.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$20.2M $54.8M +$133M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$154M -$51.3M -$80.4M -276% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$73.2M -$34.5M -$39.7M -771% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$33.5M $10.9M -$8.45M -43.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 -$25M -$78.7M -$115M -315% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $90.1M $29.1M +$9.97M +52.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $80.2M $5.14M +$119M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 -$38.6M $19.3M +$18.1M +1462% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$56.7M $36.5M +$1.01M +2.84% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$57.8M $19.1M -$10M -34.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$47.7M -$114M -$148M -431% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $100M $1.24M -$25.2M -95.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $125M $35.5M -$6.6M -15.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $132M $29.2M -$3.18M -9.83% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $135M $34.3M +$20.6M +150% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $115M $26.4M -$3.51M -11.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $118M $42.1M +$11.5M +37.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $107M $32.3M +$280K +0.87% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $106M $13.7M -$19.9M -59.1% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $126M $29.9M +$5.72M +23.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $121M $30.6M +$11.3M +58.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $109M $32.1M +$15M +88.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $94.2M $33.6M +$1.57M +4.89% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 $92.7M $24.2M +$5.89M +32.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $86.8M $19.4M -$4.26M -18% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $91M $17M -$607K -3.44% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $91.6M $32.1M +$141M Oct 1, 2013 Dec 31, 2013 10-K 2016-02-23
Q3 2013 -$49.2M $18.3M +$5.48M +42.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 -$54.7M $23.6M +$17M +258% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 -$71.7M $17.6M +$12.1M +220% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$83.8M -$109M Oct 1, 2012 Dec 31, 2012 10-K 2015-02-24
Q3 2012 $12.9M +$12.9M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 $6.59M +$6.59M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $5.52M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-07
Q3 2011 $0 Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $0 Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.